KYOWA HAKKO KIRIN CO LTD |
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 05-07 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
| 05-06 | Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April | MT |
Chart calendar Kyowa Hakko Kirin Co Ltd
761c5e.pevtNyJKpLH3f3LLp8YwIMDXBh9BAMFXumh3e3RrGmE.0oSJQHsoy4m8Dhe5yI5SEI2xaUoRbqYfiSY0KA4odln3mrwDQCjz-I4dFQ~eebfaa9fd5966f82abf950425afdd60b
Upcoming events on Kyowa Hakko Kirin Co Ltd
Past events on Kyowa Hakko Kirin Co Ltd
| 2024-05-11 11:45 | American Society of Gene & Cell Therapy Meeting - Francesco Gazzo |
| 2024-05-10 12:00 | American Society of Gene & Cell Therapy Meeting - Poster #1903 |
| 2024-05-10 12:00 | American Society of Gene & Cell Therapy Meeting - Poster #1904 |
| 2024-05-10 12:00 | American Society of Gene & Cell Therapy Meeting - Poster #1905 |
| 2024-05-09 12:00 | American Society of Gene & Cell Therapy Meeting - Poster #1136 |
| 2024-05-09 09:18 | American Society of Gene & Cell Therapy Meeting - Pervinder Sagoo |
| 2024-05-08 17:15 | Association for Research in Vision and Ophthalmology Meeting - Poster Number A0009 |
| 2024-05-08 11:15 | American Society of Gene & Cell Therapy Meeting - Alessandro Aiuti |
| 2024-05-07 13:30 | American Society of Gene & Cell Therapy Meeting - Maria Ester Bernardo |
| 2024-05-06 | Q1 2024 Earnings Release |
| 2024-04-15 19:30 | American Academy of Neurology Meeting |
| 2024-03-09 14:30 | American Academy of Dermatology Meeting |
| 2024-03-07 | American Academy of Dermatology Meeting - Rocatinlimab Significantly Improves Clinical Responses in |
| 2024-02-06 | Q4 2023 Earnings Release |
| 2023-12-27 | Final dividend |
| 2023-11-02 10:00 | American Society of Nephrology Kidney Conference - Poster Number: TH-PO145 |
| 2023-11-02 10:00 | American Society of Nephrology Kidney Conference - Poster Number: TH-PO144 |
| 2023-10-31 | Q3 2023 Earnings Call |
| 2023-10-31 | Q3 2023 Earnings Release |
| 2023-10-15 16:30 | American Society for Bone and Mineral Research Meeting - Poster #SUN-496 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 305 820 305 436 0.13% | 318 352 319 922 -0.49% | 352 246 350 570 0.48% | 398 371 396 550 0.46% | 442 233 429 390 2.99% | 474 023 |
|
EBITDA Million JPY | Released Forecast Spread | 74 170 71 401 3.88% | 79 456 78 740 0.91% | 80 611 84 158 -4.22% | 105 176 94 637 11.14% | 117 881 109 998 7.17% | 109 448 |
|
EBIT Million JPY | Released Forecast Spread | 55 373 55 148 0.41% | 58 990 63 276 -6.77% | 61 111 65 891 -7.25% | 82 374 78 312 5.19% | 95 842 89 370 7.24% | 87 211 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 44 492 45 206 -1.58% | 52 263 57 422 -8.98% | 60 050 62 960 -4.62% | 67 572 70 333 -3.93% | 97 246 91 459 6.33% | 88 157 |
|
Net income Million JPY | Released Forecast Spread | 67 084 65 391 2.59% | 47 027 47 510 -1.02% | 52 347 49 081 6.65% | 53 573 54 481 -1.67% | 81 188 73 168 10.96% | 66 798 |
|
EPS JPY | Released Forecast Spread | 125 121 3.08% | 87,6 87,5 0.08% | 97,4 91,3 6.74% | 99,7 101 -1.68% | 151 136 10.96% | 126 |
| Announcement Date | 05/02/20 | 04/02/21 | 07/02/22 | 07/02/23 | 07/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2021 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 154 404 152 541 1.22% | 157 819 159 000 -0.74% | 165 021 172 267 -4.21% | 87 751 90 640 -3.19% | 97 520 95 150 2.49% | 185 271 181 550 2.05% | 98 504 102 900 -4.27% | 114 596 109 875 4.3% | 93 535 100 141 -6.6% | 105 674 110 283 -4.18% | 199 209 204 234 -2.46% | 106 844 111 138 -3.86% | 136 180 119 018 14.42% | 105 569 104 728 0.8% | 116 159 | 216 813 | 120 609 | 130 505 |
|
EBITDA Million JPY | Released Forecast Spread | 41 558 30 327 37.03% | 23 003 23 196 -0.83% | 28 228 | 25 700 | 30 639 | |||||||||||||
|
EBIT Million JPY | Released Forecast Spread | 22 760 24 595 -7.46% | 34 564 32 500 6.35% | 30 949 35 800 -13.55% | 17 340 16 563 4.69% | 20 192 17 379 16.19% | 37 532 35 100 6.93% | 20 683 19 306 7.13% | 24 159 19 108 26.43% | 16 177 20 188 -19.87% | 20 500 26 400 -22.35% | 37 500 46 203 -18.84% | 23 405 28 757 -18.61% | 34 937 24 441 42.94% | 17 397 18 532 -6.13% | 20 579 | 39 933 | 23 257 | 25 847 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 22 663 23 821 -4.86% | 30 872 32 200 -4.12% | 31 102 35 600 -12.63% | 18 716 16 617 12.63% | 24 763 17 229 43.73% | 43 479 34 650 25.48% | 16 925 20 106 -15.82% | 7 168 | 15 582 20 159 -22.7% | 10 464 27 800 -62.36% | 26 046 46 328 -43.78% | 38 293 40 677 -5.86% | 32 907 18 250 80.31% | 18 101 18 746 -3.44% | 20 578 | 40 058 | 23 500 | 26 087 |
|
Net income Million JPY | Released Forecast Spread | 19 021 17 755 7.13% | 27 798 24 900 11.64% | 25 072 27 800 -9.81% | 16 038 13 183 21.65% | 18 979 13 579 39.77% | 35 017 27 750 26.19% | 14 195 15 756 -9.91% | 4 361 | 12 760 16 004 -20.27% | 8 886 22 600 -60.68% | 21 646 37 353 -42.05% | 31 908 36 527 -12.65% | 27 634 12 215 126.23% | 14 632 13 639 7.28% | 15 325 | 29 946 | 18 656 | 18 328 |
|
EPS JPY | Released Forecast Spread | 51,8 46,4 11.55% | 46,7 51,9 -10.08% | 29,9 24,9 20.02% | 35,3 24,4 44.97% | 65,2 51,5 26.52% | 26,4 28,9 -8.58% | 8,11 4,25 90.82% | 23,7 28,6 -17.07% | 16,5 29,8 -44.6% | 40,3 73,3 -45.06% | 59,4 46,3 28.06% | 51,4 41,4 24.33% | 27,3 28,9 -5.56% | 30,7 | 79,1 | 34,2 | 31,5 | |
| Announcement Date | 05/02/20 | 30/07/20 | 03/08/21 | 10/05/22 | 04/08/22 | 04/08/22 | 04/11/22 | 07/02/23 | 10/05/23 | 03/08/23 | 03/08/23 | 01/11/23 | 07/02/24 | 07/05/24 | - | - | - | - |
More events
Past sector events for Kyowa Hakko Kirin Co Ltd
| 2024-05-15 01:00 | MERCK KGAA: Q1 2024 Earnings Release |
| 2024-05-12 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 | OSCOTEC INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-08 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-08 16:05 | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-06 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
| 2024-04-29 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-29 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
| 2024-04-29 | YUHAN CORPORATION: Q1 2024 Earnings Release |
- Stock Market
- Equities
- 4151 Stock
- Stock
- Calendar Kyowa Hakko Kirin Co Ltd